Actionable news
All posts from Actionable news
Actionable news in IBB: iShares NASDAQ Biotechnology Index Fund,

Pfizer buying Anacor Pharmaceuticals in $5.2B deal

View photo

FILE - In this Monday, Nov. 23, 2015, file photo, a man enters Pfizer's world headquarters, in New York. Pfizer is buying Anacor Pharmaceuticals Inc. in a deal announced Monday, May 16, 2016. (AP Photo/Mark Lennihan, File)

NEW YORK (AP) -- Pfizer will acquire Anacor Pharmaceuticals Inc. in a deal valued at about $5.2 billion.

Anacor's topical treatment for eczema, called crisaborole, is currently under review by the Food and Drug Administration. If...